首页 | 本学科首页   官方微博 | 高级检索  
     


Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis: a Case Report
Authors:Jing Xie  Xiang Zhang  Bao-zhi Fang  Guang-sheng He  Yun Zhao  De-pei Wu
Affiliation:Jing Xie (Key Laboratory of Thrombosis and Hemostasis of Ministry of Health,the First Affiliated Hospital of Soochow University, Suzhou 215006, China); Xiang Zhang (Key Laboratory of Thrombosis and Hemostasis of Ministry of Health,the First Affiliated Hospital of Soochow University, Suzhou 215006, China); Bao-zhi Fang (Key Laboratory of Thrombosis and Hemostasis of Ministry of Health,the First Affiliated Hospital of Soochow University, Suzhou 215006, China); Guang-sheng He (Key Laboratory of Thrombosis and Hemostasis of Ministry of Health,the First Affiliated Hospital of Soochow University, Suzhou 215006, China); Yun Zhao (Cyrus Tang Hematology Center, Jiangsu Institute of Hematology,the First Affiliated Hospital of Soochow University, Suzhou 215006, China); De-pei Wu (Key Laboratory of Thrombosis and Hemostasis of Ministry of Health,the First Affiliated Hospital of Soochow University, Suzhou 215006, China);
Abstract:
Keywords:chronic myeloid leukemia  imatinib  imatinib-resistent  rapamycin  mammaliantarget of rapamycin
本文献已被 维普 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号